Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-031041
Filing Date
2010-05-28
Accepted
2010-05-28 13:56:13
Documents
1
Period of Report
2010-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4149
  Complete submission text file 0001209191-10-031041.txt   5850
Mailing Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Issuer) CIK: 0001128495 (see all company filings)

EIN.: 223193172 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 115 POWERS ROAD SUDBURY MA 01776
Business Address
Holtzman Steven H (Reporting) CIK: 0001300247 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50632 | Film No.: 10865852